An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC
Clinical trial NCT02409368 · COMPLETED
Trial details
- NCT number
- NCT02409368
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-29
- Primary completion
- 2018-03-07
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.